まとめ
この研究では,精神的に遅れた患者の尿中の有機酸を分析し,約5%で異常なレベルを発見しました. 主要な発見は,フェニルケトンウリアとベンゾ酸値上昇であり,さらなる調査が必要である.
科学分野:
- バイオケミストリー バイオケミストリー
- 臨床化学 臨床化学について
- メタボロミクスとは
背景:
- 精神障害は,さまざまな病因を持つ複雑な状態です.
- 生化学的マーカーを特定することは,認知障害の理解と診断に役立ちます.
研究 の 目的:
- 精神障害患者における異常非アミノ有機酸性尿の有病率を調査する.
- 精神障害に関連する特定の有機酸異常を特定する.
主な方法:
- 尿検体の定量抽出とガスクロマトグラフィ.
- ガスクロマトグラフィー-質量スペクトロメトリを用いた有機酸の識別.
- 1778人の精神障害患者と420人の対照群の分析.
主要な成果:
- 患者の約5%が異常な有機酸性尿を示した.
- 異常率が高い (7%) は,重度の不正常な子供に見られていました.
- 常見の異常は,フェニララニン代謝物 (フェニルケトノニア),ベンゾ酸の増加,および2酸化グルタール酸の増加を含んでいた.
結論:
- 異常な有機酸プロファイルは,精神的に遅滞した個人のサブセットに存在します.
- フェニルケトノウリアやベンゾ酸代謝の変化などの特定の代謝障害は,精神障害と関連しています.
- これらの生化学的発見の臨床的意義を明らかにするために,さらなる研究が必要である.
関連する概念動画
Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


